Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Intellectual Property Watch

Intellectual Property Law

: Intellectual Property Watch

The 2011 Drug Patent ?Cliff? And The Evolution Of IP Valuation

By Intellectual Property Watch

In today?s global economy, there is an increasing convergence of intellectual property and finance. Wall Street is grappling with how to recognise the true value of a firm?s intellectual property. Companies are realising that simply accumulating patents does not necessarily increase their firms? value, but it is how those patents are used that can attract capital. And drug companies facing massive numbers of upcoming patent expiries, a deflated economy and other market pressures, are looking to diversify their portfolios to stay in the black.

Related Articles:

• Brazilian Generic Drug Registration Sets Standard For ‘Pipeline’ Patents
• The Top Legal IP Issues In The United States In 2011
• UNITAID-Backed Patent Pool Final; Drug Licence Talks Can Begin

Full post as published by Intellectual Property Watch on January 11, 2011 (boomark / email).